Clinical trial
Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic…
NCT00128895 · University Medical Center Groningen, Other · Terminated
Key facts
| NCT number | NCT00128895 |
|---|---|
| Title | Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis |
| Official title | Prevention of Relapses in PR3-ANCA-associated Vasculitis, a Tailored Approach |
| Lead sponsor | University Medical Center Groningen, Other |
| Collaborators | ZonMw: The Netherlands Organisation for Health Research and Development Dutch Arthritis Association Industry Dutch Kidney Foundation |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Vasculitis |
| Intervention type | Drug |
| Interventions | azathioprine |
| Enrollment | 131 |
| Start date | Jun 1, 2003 |
| Primary completion | Jun 1, 2014 |
| Completion | Dec 1, 2014 |
| First posted | Aug 10, 2005 |
| Last update posted | Dec 13, 2018 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: